Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · IEX Real-Time Price · USD
5.55
+0.33 (6.32%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Company Description
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases.
The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Holdings Limited
Country | Hong Kong |
Founded | 2014 |
IPO Date | Jul 16, 2021 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 12 |
CEO | Yat-Gai Au |
Contact Details
Address: 11/f First Commercial Building, 33-35 Leighton Road, Causeway Bay Hong Kong, K3 999077 Hong Kong | |
Phone | 852 2155 0823 |
Website | regencellbioscience.com |
Stock Details
Ticker Symbol | RGC |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
IPO Price | $9.50 |
CIK Code | 0001829667 |
CUSIP Number | G7487R100 |
ISIN Number | KYG7487R1002 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Yat-Gai Au | Founder, Chairman and Chief Executive Officer |
Michelle Chan | Financial Controller |
Wai Hong Chung | Chief Operating Officer and Chief Strategy Officer |
Dr. Yi-Chung Chao Ph.D. | Special Advisor and Director |
Tien Hsiang Chau | Executive Officer |
Antonia Assang | Senior Vice President of Project Management |
Yat-Pui Au | Chief Business Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 2, 2024 | 6-K | Report of foreign issuer |
Dec 15, 2023 | 6-K | Report of foreign issuer |
Oct 27, 2023 | 20-F | Annual and transition report of foreign private issuers |
Jun 15, 2023 | 6-K | Report of foreign issuer |
Jun 5, 2023 | 6-K | Report of foreign issuer |
Mar 17, 2023 | 6-K | Report of foreign issuer |
Feb 28, 2023 | 6-K | Report of foreign issuer |
Jan 4, 2023 | 6-K | Report of foreign issuer |
Dec 22, 2022 | 6-K | Report of foreign issuer |
Oct 31, 2022 | 20-F | Annual and transition report of foreign private issuers |